Roche unit TIB MOLBIOL launches LightMix newborn screening test in CE mark countries

• TIB MOLBIOL, a Roche Diagnostics unit, launched the LightMix Newborn TREC/SMN1/HBB screening kit in CE mark markets.
• Test screens newborns for SMA, SCID, SCD in a single run, expanding Roche’s early diagnostics portfolio.
• IVDR-approved kit targets private, academic hospital labs with a ready-to-use assay designed to fit existing workflows on LightCycler systems.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roche Holding AG published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609300100PR_NEWS_USPR_____SF59371) on September 30, 2026, and is solely responsible for the information contained therein.